Mercer Global Advisors
JAZZ icon

Mercer Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mercer Global Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Buy
11,117
+4,170
+60% +$729K ﹤0.01% 1179
2025
Q4 		$1.18M Buy
6,947
+4,467
+180% +$685K ﹤0.01% 1368
2025
Q3 		$327K Sell
2,480
-564
-19% -$67.6K ﹤0.01% 2027
2025
Q2 		$323K Buy
3,044
+1,332
+78% +$145K ﹤0.01% 1813
2025
Q1 		$213K Buy
1,712
+71
+4% +$9.26K ﹤0.01% 1938
2024
Q4 		$202K Sell
1,641
-1,686
-51% -$199K ﹤0.01% 1968
2024
Q3 		$371K Sell
3,327
-158
-5% -$17.3K ﹤0.01% 1514
2024
Q2 		$372K Buy
3,485
+1,187
+52% +$131K ﹤0.01% 1470
2024
Q1 		$277K Sell
2,298
-365
-14% -$44.7K ﹤0.01% 1609
2023
Q4 		$328K Sell
2,663
-112
-4% -$14K ﹤0.01% 1554
2023
Q3 		$359K Buy
2,775
+79
+3% +$10.5K ﹤0.01% 1418
2023
Q2 		$334K Sell
2,696
-632
-19% -$85K ﹤0.01% 1452
2023
Q1 		$487K Sell
3,328
-625
-16% -$92.4K ﹤0.01% 1219
2022
Q4 		$630K Sell
3,953
-111
-3% -$16.3K ﹤0.01% 1101
2022
Q3 		$542K Sell
4,064
-505
-11% -$76.8K ﹤0.01% 1096
2022
Q2 		$713K Sell
4,569
-257
-5% -$39.6K ﹤0.01% 984
2022
Q1 		$751K Sell
4,826
-1,722
-26% -$250K ﹤0.01% 1027
2021
Q4 		$834K Sell
6,548
-599
-8% -$78.7K 0.01% 969
2021
Q3 		$931K Sell
7,147
-4,114
-37% -$622K 0.01% 887
2021
Q2 		$2M Sell
11,261
-515
-4% -$89.2K 0.02% 571
2021
Q1 		$1.94M Sell
11,776
-617
-5% -$102K 0.02% 530
2020
Q4 		$2.04M Sell
12,393
-24,223
-66% -$3.61M 0.03% 414
2020
Q3 		$5.22M Sell
36,616
-163
-0.4% -$20.2K 0.08% 192
2020
Q2 		$4.06M Buy
36,779
+8,779
+31% +$971K 0.07% 194
2020
Q1 		$2.79M Buy
28,000
+24,919
+809% +$3.22M 0.06% 252
2019
Q4 		$460K Buy
3,081
+336
+12% +$45.7K 0.01% 760
2019
Q3 		$351K Sell
2,745
-82
-3% -$11K 0.01% 837
2019
Q2 		$403K Buy
2,827
+258
+10% +$34.7K 0.01% 760
2019
Q1 		$367K Buy
+2,569
New +$335K 0.01% 749

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Mercer Global Advisors's JAZZ Position: Q1 2026 in Review

Mercer Global Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 60% in Q1 2026, buying an estimated $729K and bringing the position to 11,117 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Mercer Global Advisors first reported a position in JAZZ in Q1 2019 and has held it in 29 quarters since. The position peaked at $5.22M in Q3 2020. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Mercer Global Advisors held 11,117 shares of Jazz Pharmaceuticals worth $2.1M as of Q1 2026.
  • Mercer Global Advisors bought 4,170 Jazz Pharmaceuticals shares in Q1 2026, an estimated $729K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #1179 holding.
  • Mercer Global Advisors first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 29 quarters since.
  • Mercer Global Advisors's Jazz Pharmaceuticals position peaked at $5.22M in Q3 2020.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.